Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > questions
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(29)
•••
Comment by ChiChi3on Aug 04, 2010 12:15pm
433 Views
Post# 17320776

RE: RE: RE: RE: questions

RE: RE: RE: RE: questionsBornReady1970 is pretty much right.  It will take 1-2 years to do the trial and ask apply for FDA approval and the only way for ISA to continue beyond 2010 is for dillution or selling off future revenue potential.  Either way, it will make the last Paladin deal look extremely attractive by comparison. 

I might further suggest that there is something seriously wrong with Voclosporin (ie. safety) for the need for a whole new trial.  That would surely sink the company if this is the reason for the new trial. 

I'm officially out after 10+ years.  I may get back in at 3-5 cents if there is more clarity on the reason for the trial.

Chi.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities